Primary malignancies found in the study population
| Primary malignancy | No of patients | No of ever smokers (% by malignancy type) |
|---|---|---|
| *Includes one case each of benign metastasising leiomyosarcoma, osteogenic sarcoma, uterine sarcoma, synovial cell sarcoma, and chondrosarcoma, as well as two cases of unspecified sarcomas. | ||
| †All tumour types were analysed individually. Because some patients had more than one primary tumour, the sum of all figures in a given column may exceed that reported as the total. | ||
| Group 1 | ||
| Head/neck | 11 | 9 (82) |
| Group 2 | ||
| Bladder | 12 | 9 (75) |
| Breast | 64 | 41 (64) |
| Cervix | 1 | 0 (0) |
| Oesophagus | 2 | 1 (50) |
| Ovary | 2 | 1 (50) |
| Prostate | 15 | 11 (73) |
| Subtotal | 96 | 63 (67) |
| Group 3 | ||
| Colon | 15 | 10 (67) |
| Rectum | 4 | 2 (50) |
| Liver | 1 | 1 (100) |
| Carcinoid | 1 | 1 (100) |
| Adrenal | 1 | 0 (0) |
| Kidney | 6 | 1 (17) |
| Uterus | 6 | 3 (50) |
| Subtotal | 34 | 18 (53) |
| Group 4 | ||
| Thymus | 1 | 0 (0) |
| Melanoma | 8 | 6 (75) |
| Sarcoma* | 7 | 5 (71) |
| Testes | 4 | 3 (75) |
| Kaposi’s sarcoma | 2 | 2 (100) |
| Subtotal | 22 | 16 (73) |
| Total† | 151 | 101 (67) |